These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11146896)

  • 21. [Psoriatic arthritis: combined treatment with prospidin and methotrexate].
    Simonova OV; Nemtsov BF
    Ter Arkh; 2005; 77(8):60-4. PubMed ID: 16206608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.
    Utset TO; Auger JA; Peace D; Zivin RA; Xu D; Jolliffe L; Alegre ML; Bluestone JA; Clark MR
    J Rheumatol; 2002 Sep; 29(9):1907-13. PubMed ID: 12233885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of etanercept for psoriatic arthritis in the dermatology clinic: the Experience Diagnosing, Understanding Care, and Treatment with Etanercept (EDUCATE) study.
    Gottlieb AB; Kircik L; Eisen D; Jackson JM; Boh EE; Strober BE; Frankel E; Xia HA; Stevens SR
    J Dermatolog Treat; 2006; 17(6):343-52. PubMed ID: 17853307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Puerto Rico psoriasis study group: efficacy and safety of etanercept.
    González-Chavez JR; Berlingeri-Ramos AC; Sánchez Casiano MA
    J Drugs Dermatol; 2005; 4(6):735-9. PubMed ID: 16302559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.
    Kaltwasser JP; Nash P; Gladman D; Rosen CF; Behrens F; Jones P; Wollenhaupt J; Falk FG; Mease P;
    Arthritis Rheum; 2004 Jun; 50(6):1939-50. PubMed ID: 15188371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Use of cyclosporin A in chronic polyarthritis and other rheumatic diseases].
    Krüger K
    Z Rheumatol; 1995; 54(2):89-95. PubMed ID: 7793161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrastructural findings and tumor necrosis factor-alpha and intercellular adhesion molecule-1 expression in psoriasis patients before and after oral cyclosporin A therapy.
    Eşrefoğlu M; Gül M; Seyhan M
    Ultrastruct Pathol; 2006; 30(1):95-102. PubMed ID: 16517475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chloroquine in the treatment of psoriatic arthritis].
    Jajić Z; Jajić I; Grazio S
    Reumatizam; 1995; 42(2):7-9. PubMed ID: 8693205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidisciplinary focus on cyclosporin A.
    Salvarani C; Boiardi L; Macchioni P; Pipitone N; Catanoso M; Pigatto P
    J Rheumatol Suppl; 2009 Aug; 83():52-5. PubMed ID: 19661542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic efficacy of oral low-dose cyclosporin A in severe psoriatic arthritis.
    Wagner SA; Peter RU; Adam O; Ruzicka T
    Dermatology; 1993; 186(1):62-7. PubMed ID: 8435521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Healing of severe ulcerative necrobiosis lipoidica with cyclosporin.
    Stanway A; Rademaker M; Newman P
    Australas J Dermatol; 2004 May; 45(2):119-22. PubMed ID: 15068460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The efficacy of diclonate P in psoriatic arthritis].
    Burdeĭnyĭ AP
    Ter Arkh; 1994; 66(5):75-7. PubMed ID: 7940348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile.
    Takeda A; Horike K; Onoda H; Ohtsuka Y; Yoshida A; Uchida K; Morozumi K
    Nephrology (Carlton); 2007 Apr; 12(2):197-204. PubMed ID: 17371346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation.
    Antoni C; Dechant C; Hanns-Martin Lorenz PD; Wendler J; Ogilvie A; Lueftl M; Kalden-Nemeth D; Kalden JR; Manger B
    Arthritis Rheum; 2002 Oct; 47(5):506-12. PubMed ID: 12382299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclosporin A treatment for idiopathic membranous nephropathy.
    Yao X; Chen H; Wang Q; Tang Z; Hu W; Yin G; Liu Z; Li L
    Chin Med J (Engl); 2001 Dec; 114(12):1305-8. PubMed ID: 11793859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Infliximab].
    Herrera E; Habicheyn S
    Actas Dermosifiliogr; 2008 Jul; 99 Suppl 4():7-13. PubMed ID: 19080986
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical usefulness and patient satisfaction for treatment with low-dose cyclosporin administration in patients with moderate psoriasis vulgaris.
    Abe M; Ishibuchi H; Syuto T; Sogabe Y; Yokoyama Y; Ishikawa O
    J Dermatol; 2007 May; 34(5):290-3. PubMed ID: 17408436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate and cyclosporin combined therapy in severe psoriatic arthritis. A pilot study.
    Mazzanti G; Coloni L; De Sabbata G; Paladini G
    Acta Derm Venereol Suppl (Stockh); 1994; 186():116-7. PubMed ID: 8073808
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.